ReNeuron Company Profile

16:10 EDT 26th September 2017 | BioPortfolio

ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.


Europoint Centre , 5-11 Lavington Street
United Kingdom


Phone: 0207 928 1720
Fax: 0207 261 0268

News Articles [23 Associated News Articles listed on BioPortfolio]

ReNeuron Group (RENE) - Milestones expected as pipeline progresses

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: The highlight of FY17 was positive Phase II efficacy data from ReNeuron’s PISCES II clinical trial. As this and its oth...

Reneuron awarded £1.8mln to upgrade Wales facility

Stem cell specialist ReNeuron Group Plc (LON:RENE)  has been awarded a £1.8mln grant from Innovate UK, the UK government’s tech arm, to develop its commercial cell therapy manufacturing skills...

ReNeuron secures £1.8m grant to optimize cell therapy manufacturing processes

Innovate UK has awarded ReNeuron Group a £1.8m grant to further advance its next generation commercial cell therapy manufacturing capabilities.

Retinal stem cell therapy drug from ReNeuron wins FDA nod

ReNeuron Group's retinal stem cell therapy candidate in a cryopreserved formulation has been approved by the FDA. -More- 

ReNeuron set the broaden scope of eye disease research after regulatory sign-off for frozen cell line

The American regulator has approved a cryopreserved formulation of ReNeuron Group Plc’s (LON:RENE) cell therapy for degenerative diseases of the retina. The US Food & Drug Administration (FDA)...

ReNeuron Outlines First-To-Market Plans For Stroke Disability Cell Therapy

ReNeuron has high hopes of being the first to reach the US market with a novel stem cell therapy for...    

ReNeuron posts 'very significant' exosome therapy data at Toronto conference

ReNeuron Group Plc (LON:RENE) has published what it describes as very significant data highlighting the ability of its exosome therapy candidate to target specific organs of the body. Exosome therap...

ReNeuron Spies SPA and RMAT For Stem Cell Stroke Therapy

UK cell therapeutics firm ReNeuron has released its late-stage development strategy for its novel stem cell therapy for stroke disability...  

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

More Information about "ReNeuron" on BioPortfolio

We have published hundreds of ReNeuron news stories on BioPortfolio along with dozens of ReNeuron Clinical Trials and PubMed Articles about ReNeuron for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReNeuron Companies in our database. You can also find out about relevant ReNeuron Drugs and Medications on this site too.

Quick Search

Relevant Topics

Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record